| Breast cancer prognostic classification in the molecular era: the role of histological grade EA Rakha, JS Reis-Filho, F Baehner, DJ Dabbs, T Decker, V Eusebi, ... Breast cancer research 12, 1-12, 2010 | 1214 | 2010 |
| Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists S Badve, DJ Dabbs, SJ Schnitt, FL Baehner, T Decker, V Eusebi, SB Fox, ... Modern pathology 24 (2), 157-167, 2011 | 919 | 2011 |
| BRCA1 dysfunction in sporadic basal-like breast cancer NC Turner, JS Reis-Filho, AM Russell, RJ Springall, K Ryder, D Steele, ... Oncogene 26 (14), 2126-2132, 2007 | 727 | 2007 |
| Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype S Ricardo, AF Vieira, R Gerhard, D Leitão, R Pinto, JF Cameselle-Teijeiro, ... Journal of clinical pathology 64 (11), 937-946, 2011 | 704 | 2011 |
| P-Cadherin Overexpression Is an Indicator of Clinical Outcome in Invasive Breast Carcinomas and Is Associated with CDH3 Promoter Hypomethylation J Paredes, A Albergaria, JT Oliveira, C Jerónimo, F Milanezi, FC Schmitt Clinical cancer research 11 (16), 5869-5877, 2005 | 560 | 2005 |
| Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer C Costa, R Soares, JS Reis-Filho, D Leitao, I Amendoeira, FC Schmitt Journal of clinical pathology 55 (6), 429-434, 2002 | 494 | 2002 |
| Role of monocarboxylate transporters in human cancers: state of the art C Pinheiro, A Longatto-Filho, J Azevedo-Silva, M Casal, FC Schmitt, ... Journal of bioenergetics and biomembranes 44, 127-139, 2012 | 455 | 2012 |
| Metaplastic breast carcinomas are basal‐like tumours JS Reis‐Filho, F Milanezi, D Steele, K Savage, PT Simpson, JM Nesland, ... Histopathology 49 (1), 10-21, 2006 | 443 | 2006 |
| Phyllodes tumours of the breast: a consensus review BY Tan, G Acs, SK Apple, S Badve, IJ Bleiweiss, E Brogi, JP Calvo, ... Histopathology 68 (1), 5-21, 2016 | 435 | 2016 |
| Pathology of ovarian cancers in BRCA1 and BRCA2 carriers SR Lakhani, S Manek, F Penault-Llorca, A Flanagan, L Arnout, S Merrett, ... Clinical Cancer Research 10 (7), 2473-2481, 2004 | 374 | 2004 |
| FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas JS Reis-Filho, PT Simpson, NC Turner, MB Lambros, C Jones, A Mackay, ... Clinical Cancer Research 12 (22), 6652-6662, 2006 | 336 | 2006 |
| Epithelial E-and P-cadherins: role and clinical significance in cancer J Paredes, J Figueiredo, A Albergaria, P Oliveira, J Carvalho, AS Ribeiro, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1826 (2), 297-311, 2012 | 333 | 2012 |
| p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas I Matos, R Dufloth, M Alvarenga, LC Zeferino, F Schmitt Virchows Archiv 447, 688-694, 2005 | 332 | 2005 |
| EGFR amplification and lack of activating mutations in metaplastic breast carcinomas JS Reis‐Filho, C Pinheiro, MBK Lambros, F Milanezi, S Carvalho, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 313 | 2006 |
| Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas C Pinheiro, A Longatto-Filho, C Scapulatempo, L Ferreira, S Martins, ... Virchows Archiv 452, 139-146, 2008 | 305 | 2008 |
| The role of osteopontin in tumor progression and metastasis in breast cancer LR Rodrigues, JA Teixeira, FL Schmitt, M Paulsson, ... Cancer Epidemiology Biomarkers & Prevention 16 (6), 1087-1097, 2007 | 301 | 2007 |
| Wound healing activity of the human antimicrobial peptide LL37 R Ramos, JP Silva, AC Rodrigues, R Costa, L Guardão, F Schmitt, ... Peptides 32 (7), 1469-1476, 2011 | 277 | 2011 |
| Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray JS Reis-Filho, PT Simpson, A Martins, A Preto, F Gärtner, FC Schmitt Virchows Archiv 443, 122-132, 2003 | 270 | 2003 |
| Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions … N Lopes, B Sousa, D Martins, M Gomes, D Vieira, LA Veronese, ... BMC cancer 10, 1-10, 2010 | 262 | 2010 |
| Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression I Carvalho, F Milanezi, A Martins, RM Reis, F Schmitt Breast Cancer Research 7, 1-8, 2005 | 258 | 2005 |
